title: Palmaz-Schatz stent for hepatic artery stenosis during hepatic arterial infusion chemotherapy.
abstract: Hepatic arterial infusion chemotherapy using an implantable port system was performed on a 40 year-old man with advanced hepatocellular carcinoma. When the in-dwelling catheter was inserted into the common hepatic artery (CHA), intimal dissection occurred as a result of the catheterization causing severe stenosis. On day 55 after intimal dissection, an in-dwelling Palmaz-Schatz stent was inserted after percutaneous transluminal angioplasty (PTA). CHA blood flow was shown to have improved on Digital subtraction angiography (DSA) and Doppler ultrasound after the in-dwelling Palmaz-Schatz stent. Thus a partial response was shown. The DSA from the implantable port system showed adequate patency 6 months after. This is the first report describing the usefulness of a Palmaz-Schatz stent for the severe stenosis of the CHA caused by the technique of catheterization.
authors.affiliation: Department of Surgery, Kurume University Hospital, Fukuoka, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Ogata
authors.forename: K
authors.initials: K
authors.lastname: Okuda
authors.forename: J
authors.initials: J
authors.lastname: Nagashima
authors.forename: H
authors.initials: H
authors.lastname: Kinoshita
authors.forename: T
authors.initials: T
authors.lastname: Nakayama
authors.forename: S
authors.initials: S
authors.lastname: Aoyagi
authors.forename: K
authors.initials: K
authors.lastname: Ichiki
authors.forename: T
authors.initials: T
authors.lastname: Ueno
mesh_terms: D000328:Adult; D015901:Angiography, Digital Subtraction; D000800:Angioplasty, Balloon; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002408:Catheters, Indwelling / Q000009:adverse effects*; D006499:Hepatic Artery / Q000000981:diagnostic imaging; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D015607:Stents
chemical_list: D000970:Antineoplastic Agents